Physician profile
Bradley Egbert
NPI 1902885007
$260.56
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $11.76 · 2021: $82.26 · 2022: $19.22.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Comsort, INC | $100.00 | 2019 | |
| Edwards Lifesciences Corporation | $49.37 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $30.56 | 2021 | |
| Novartis Pharmaceuticals Corporation | $19.22 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $18.47 | 2019 | |
| Avanos Medical | $16.71 | 2021 | |
| Elutia, INC. | $14.47 | 2021 | |
| Covidien LP | $11.76 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Egbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.